FDA Approves Extended-Release Xeljanz for Adults with Ulcerative Colitis
News
The U.S. Food and Drug Administration (FDA) has approved Pfizer‘s extended-release tablets of Xeljanz XR (tofacitinib) to treat adults with moderately to severely active ulcerative colitis. This approval of 11 mg ... Read more